Free Trial

Sonoma Pharmaceuticals (SNOA) SEC Filings & 10K Form

Sonoma Pharmaceuticals logo
$2.85 -0.06 (-2.06%)
(As of 11/22/2024 ET)

Recent Sonoma Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/21/2024
3:01 PM
Sonoma Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
7:36 AM
Sonoma Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/22/2024
7:30 AM
Sonoma Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
5:00 AM
Sonoma Pharmaceuticals (Filer)
Form 424B5
09/20/2024
5:02 AM
Sonoma Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2024
5:03 AM
Sonoma Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2024
7:30 AM
Sonoma Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:49 PM
Sonoma Pharmaceuticals (Filer)
Form DEFA14A
08/14/2024
7:53 PM
Sonoma Pharmaceuticals (Filer)
Form DEFA14A
07/24/2024
6:30 AM
Sonoma Pharmaceuticals (Filer)
Form DEFA14A
07/01/2024
6:30 AM
Sonoma Pharmaceuticals (Filer)
Form DEF 14A
06/27/2024
6:30 AM
Sonoma Pharmaceuticals (Filer)
Form 424B5
06/27/2024
6:31 AM
Sonoma Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
3:56 PM
Sonoma Pharmaceuticals (Filer)
Form PRE 14A
06/21/2024
4:05 PM
Dal Poggetto John (Reporting)
Sonoma Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:05 PM
DVONCH JEROME J (Reporting)
Sonoma Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:05 PM
Sonoma Pharmaceuticals (Issuer)
Thornton Bruce (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:06 PM
Sonoma Pharmaceuticals (Issuer)
Trombly Amy Moss (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
6:30 AM
Sonoma Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
6:30 AM
Sonoma Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2024
3:30 PM
Sonoma Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2024
6:30 AM
Sonoma Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
3:47 PM
Sonoma Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
4:23 PM
Sonoma Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
4:24 PM
DVONCH JEROME J (Reporting)
Sonoma Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
4:25 PM
Dal Poggetto John (Reporting)
Sonoma Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
4:25 PM
Sonoma Pharmaceuticals (Issuer)
Thornton Bruce (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
4:26 PM
Sonoma Pharmaceuticals (Issuer)
Trombly Amy Moss (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
4:30 PM
Sonoma Pharmaceuticals (Filer)
Form 424B3
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SNOA) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners